Literature DB >> 12667038

Economic analysis of influenza vaccination and treatment.

Martin I Meltzer, Carolyn B Bridges.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12667038     DOI： 10.7326/0003-4819-138-7-200304010-00024

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand.

Authors:  Bao-Zhong Wang; Harvinder S Gill; Sang-Moo Kang; Li Wang; Ying-Chun Wang; Elena V Vassilieva; Richard W Compans
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

2.  Influenza exerts continued pressure in an era of modern medicine.

Authors:  James W Noah; Diana L Noah; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-07       Impact factor: 6.914

3.  Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity.

Authors:  Bao-Zhong Wang; Harvinder S Gill; Cheng He; Changbo Ou; Li Wang; Ying-Chun Wang; Hao Feng; Han Zhang; Mark R Prausnitz; Richard W Compans
Journal:  J Control Release       Date:  2014-01-11       Impact factor: 9.776

4.  An Influenza HA and M2e Based Vaccine Delivered by a Novel Attenuated Salmonella Mutant Protects Mice against Homologous H1N1 Infection.

Authors:  Irshad A Hajam; John H Lee
Journal:  Front Microbiol       Date:  2017-05-15       Impact factor: 5.640

5.  Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions.

Authors:  Nargesalsadat Dorratoltaj; Achla Marathe; Bryan L Lewis; Samarth Swarup; Stephen G Eubank; Kaja M Abbas
Journal:  PLoS Comput Biol       Date:  2017-06-01       Impact factor: 4.475
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.